| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.007 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.008 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.008 |